Latest Breaking News On - News ratings for neurobo pharmaceuticals daily - Page 1 : comparemela.com

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Down 21 8% in April

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Down 21 8% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Maxim groupNeurobo pharmaceuticals incNews ratings for neurobo pharmaceuticals dailyNeurobo pharmaceuticalsNeurobo pharmaceuticals stock performanceGet free reportG protein coupled receptorNeurobo pharmaceuticals daily

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Update

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Neurobo pharmaceuticals company profileNews ratings for neurobo pharmaceuticals dailyNeurobo pharmaceuticalsNeurobo pharmaceuticals trading downNeurobo pharmaceuticals incGet free reportG protein coupled receptorNeurobo pharmaceuticals daily

Research Analysts Issue Forecasts for NeuroBo Pharmaceuticals, Inc s Q1 2024 Earnings (NASDAQ:NRBO)

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) – Equities researchers at Zacks Small Cap issued their Q1 2024 earnings estimates for NeuroBo Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.95) per share for the quarter. The consensus estimate for NeuroBo Pharmaceuticals’ […]

News ratings for neurobo pharmaceuticals dailyNeurobo pharmaceuticals stock performanceNeurobo pharmaceuticals incNeurobo pharmaceuticals company profileNeurobo pharmaceuticalsFree reportZacks small capSmall capNeurobo pharmaceuticalGet free reportG protein coupled receptorNeurobo pharmaceuticals dailyNasdaq nrboEarnings estimates

NeuroBo Pharmaceuticals (NASDAQ:NRBO) Shares Down 1 2%

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Free Report)’s share price traded down 1.2% during trading on Monday . The stock traded as low as $0.43 and last traded at $0.45. 123,703 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 574,195 shares. The stock had previously closed at […]

Neurobo pharmaceuticalsNeurobo pharmaceuticals company profileNeurobo pharmaceuticals incMillennium managementNews ratings for neurobo pharmaceuticals dailyInstitutional trading of neurobo pharmaceuticalsRenaissance technologiesNeurobo pharmaceuticals price performanceGet free reportSigma investmentsG protein coupled receptorNeurobo pharmaceuticals dailyNasdaq nrbo

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Sees Large Decrease in Short Interest

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, […]

Neurobo pharmaceuticals incNews ratings for neurobo pharmaceuticals dailyMillennium managementNeurobo pharmaceuticalsRenaissance technologiesNeurobo pharmaceuticals stock downFree reportSigma investmentsG protein coupled receptorNeurobo pharmaceuticals dailyNasdaq nrbo